Therefore, COL1A1 and COL1A2 are recognized as key molecular markers for MASLD fibrosis, and their expression levels can be used to assess hepatic fibrosis severity and predict therapeutic responses.41 The gene discussed is COL1A2; the disease is metabolic dysfunction-associated steatotic liver disease.